patients - International Biopharmaceutical Industry

Home
Current
Features
Editorial
Archives
Archived
Issues
Events
Sponsored
Report
Company
Profile
A-D

E-M

N-S

T-Z

Menu
Application
Notes
News
eBooks

Aldevron
Podcast
Generic selectors

Exact matches only

Search in title

Search in content

Post Type Selectors

Current Edition

news

Medicare finalizes policy limiting coverage of Biogen Alzheimer’s drug

Medicare will not pay for Biogen's new Alzheimer's medicine unless prospective patients are enrolled in a clinical trial, the U.S. government said Thursday in a decis...

11 April 2022 news Alzheimer | Biogen

Continue Reading →

news

Roche revives a closely watched Huntington’s disease drug

Dive Brief: Roche has outlined a new clinical path forward for a closely watched Huntington's disease drug ten months after disappointing Phase 3 study results app...

20 January 2022 news Disease | Huntington

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Medicare finalizes policy limiting coverage of Biogen Alzheimer’s drug

Roche revives a closely watched Huntington’s disease drug

International Biopharmaceutical Industry